– UK, Alderley Park – Redx Pharma (LON: REDX), the drug discovery and development company focused on cancer and fibrosis, today announced the appointment of Tom Burt to its Board as a Non-Executive Director effective from 4 August 2020.…
– ITALY, Milan – Enthera Pharmaceuticals, a biotech company developing disease-modifying biologics to transform the therapeutic paradigm of specific autoimmune conditions by re-establishing stem cell capabilities in a non-traditional way, today announced the completion of a €28 million Series A financing round co-led by seed investor Sofinnova Partners, and incoming investor AbbVie Ventures, with further investment from the JDRF T1D Fund and several Italian investors including a group coordinated by Banor SIM, a group coordinated by Banca Profilo through Arepo Fiduciaria and Indaco Venture Partners SGR.…
– ITALY, Milan – PinCell, a biotechnology company developing novel therapies for rare dermatological diseases, today announced the appointment of Gabriella Camboni, M.D.,…
– ITALY, Milan – Genespire, a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, today announced the successful close of a €16M Series A financing from Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan.…